Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy

被引:21
作者
Zareba, Piotr [3 ]
Eastham, James [1 ,2 ]
Scardino, Peter T. [1 ,2 ]
Touijer, Karim [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Urol Serv, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[3] McMaster Univ, Div Urol, Hamilton, ON, Canada
基金
美国国家卫生研究院;
关键词
prostatic neoplasms; prostatectomy; lymph node excision; lymphatic metastasis; mortality; ADJUVANT RADIOTHERAPY; CANCER; SURVIVAL; TRIAL; RISK;
D O I
10.1016/j.juro.2017.06.062
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: A thorough understanding of the natural history and consensus regarding the optimal management of pathological lymph node positive (pN1) prostate cancer are lacking. Our objective was to describe patterns of care and outcomes of a contemporary cohort of men with pN1 prostate cancer. Materials and Methods: We used the National Cancer Database to identify 7,791 men who were found to have lymph node metastases at radical prostatectomy. Multinomial logistic regression and Cox proportional hazards regression were used to identify patient, tumor and facility characteristics associated with the choice of management strategy after radical prostatectomy and overall survival, respectively. Results: Initial post-prostatectomy management was observation in 63% of the men, androgen deprivation therapy alone in 20%, radiation therapy alone in 5%, and androgen deprivation therapy and radiation therapy in 13%. Younger age, lower comorbidity burden, higher grade and stage, and positive surgical margins were associated with a higher likelihood of receiving combination therapy. Grade group 4-5 disease, pT3b-T4 disease, positive surgical margins and a higher number of positive lymph nodes were independent predictors of worse overall survival. The adjusted 10-year overall survival probability decreased from 84% to 32% with the presence of an increasing number of adverse prognostic factors. Treatment with combined androgen deprivation therapy and radiation therapy was associated with better overall survival (multivariable HR 0.69, 95% CI 0.52-0.92, p = 0.010 for combination therapy vs observation). Conclusions: Patient and tumor characteristics are associated with the choice of management strategy after radical prostatectomy and survival in men with pN1 prostate cancer. Multimodal therapy may be of benefit in this patient population.
引用
收藏
页码:1077 / 1084
页数:8
相关论文
共 20 条
[1]  
Abdollah F, 2013, ANN ONCOL, V24, P1459, DOI 10.1093/annonc/mdt120
[2]   Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer [J].
Abdollah, Firas ;
Karnes, R. Jeffrey ;
Suardi, Nazareno ;
Cozzarini, Cesare ;
Gandaglia, Giorgio ;
Fossati, Nicola ;
Vizziello, Damiano ;
Sun, Maxine ;
Karakiewicz, Pierre I. ;
Menon, Mani ;
Montorsi, Francesco ;
Briganti, Alberto .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) :3939-U222
[3]   Decreasing Rate and Extent of Lymph Node Staging in Patients Undergoing Radical Prostatectomy May Undermine the Rate of Diagnosis of Lymph Node Metastases in Prostate Cancer [J].
Abdollah, Firas ;
Sun, Maxine ;
Thuret, Rodolphe ;
Budaeus, Lars ;
Jeldres, Claudio ;
Graefen, Markus ;
Briganti, Alberto ;
Perrotte, Paul ;
Rigatti, Patrizio ;
Montorsi, Francesco ;
Karakiewicz, Pierre I. .
EUROPEAN UROLOGY, 2010, 58 (06) :882-892
[4]   The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients [J].
Bianchi, Lorenzo ;
Nini, Alessandro ;
Bianchi, Marco ;
Gandaglia, Giorgio ;
Fossati, Nicola ;
Suardi, Nazareno ;
Moschini, Marco ;
Dell'Oglio, Paolo ;
Schiavina, Riccardo ;
Montorsi, Francesco ;
Briganti, Alberto .
EUROPEAN UROLOGY, 2016, 69 (06) :1142-1148
[5]   Postoperative radiotherapy after radical prostatectomy:: a randomised controlled trial (EORTC trial 22911) [J].
Bolla, M ;
van Poppel, H ;
Collette, L ;
van Cangh, P ;
Vekemans, K ;
Da Pozzo, L ;
de Reijke, TM ;
Verbaeys, A ;
Bosset, JF ;
van Velthoven, R ;
Maréchal, JM ;
Scalliet, P ;
Haustermans, K ;
Piérart, M .
LANCET, 2005, 366 (9485) :572-578
[6]   Treatment of Lymph Node-Positive Prostate Cancer: Teaching Old Dogmas New Tricks [J].
Briganti, Alberto ;
Passoni, Niccolo M. ;
Abdollah, Firas ;
Nini, Alessandro ;
Montorsi, Francesco ;
Karnes, R. Jeffrey .
EUROPEAN UROLOGY, 2014, 65 (01) :26-28
[7]   Pathological Features of Lymph Node Metastasis for Predicting Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer [J].
Carlsson, Sigrid V. ;
Tafe, Laura J. ;
Chade, Daher C. ;
Sjoberg, Daniel D. ;
Passoni, Niccolo ;
Shariat, Shahrokh F. ;
Eastham, James ;
Scardino, Peter T. ;
Fine, Samson W. ;
Touijer, Karim A. .
JOURNAL OF UROLOGY, 2013, 189 (04) :1314-1318
[8]   Landmark Analysis at the 25-Year Landmark Point [J].
Dafni, Urania .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (03) :363-U216
[9]   Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy [J].
Eggener, Scott E. ;
Scardino, Peter T. ;
Walsh, Patrick C. ;
Han, Misop ;
Partin, Alan W. ;
Trock, Bruce J. ;
Feng, Zhaoyong ;
Wood, David P. ;
Eastham, James A. ;
Yossepowitch, Ofer ;
Rabah, Danny M. ;
Kattan, Michael W. ;
Yu, Changhong ;
Klein, Eric A. ;
Stephenson, Andrew J. .
JOURNAL OF UROLOGY, 2011, 185 (03) :869-875
[10]   Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy [J].
Kaplan, Joshua R. ;
Kowalczyk, Keith J. ;
Borza, Tudor ;
Gu, Xiangmei ;
Lipsitz, Stuart R. ;
Nguyen, Paul L. ;
Friedlander, David F. ;
Quoc-Dien Trinh ;
Hu, Jim C. .
BJU INTERNATIONAL, 2013, 111 (08) :1208-1214